Journavx (suzetrigine) is the first new pain drug class in 20 years. Explore trial results,…


Journavx (suzetrigine) is the first new pain drug class in 20 years. Explore trial results,…

On Sermo, physicians explore how AI is transforming drug development, from rational design to predictive…